Join to View Full Profile
200 W Arbor DrSan Diego, CA 92103
Phone+1 800-926-8273
Dr. Tuszynski is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Diego) Medical CenterResidency, Ph.D., Neurosciences, 1988 - 1991
University of California (San Diego) Medical CenterResidency, Neurology, 1987 - 1988
New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1984 - 1987
University of Minnesota Medical SchoolClass of 1983
Certifications & Licensure
NY State Medical License 1984 - Present
CA State Medical License 1986 - 2027
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Gene Therapy for Alzheimer's Disease Clinical Trial
- A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment Start of enrollment: 2022 Feb 07
Roles: Principal Investigator, Contact, Sponsor-Investigator
Publications & Presentations
PubMed
- 1 citationsOptimized genetic tracers for viral mediated neuronal projection mapping.Jennifer N Dulin, Li Ye, Teresa Grider, Anael Rizzo, Ephron S Rosenzweig
Cellular & Molecular Biology Letters. 2026-03-07 - Drug Development.Mark H Tuszynski, Douglas W Scharre, Gabriel C Leger, Russell R Lonser, Krystof S Bankiewicz
Alzheimer's & Dementia. 2025-12-01 - 4 citationsExtensive restoration of forelimb function in primates with spinal cord injury by neural stem cell transplantation.Eleni Sinopoulou, Ephron S Rosenzweig, John H Brock, Hiromi Kumamaru, Ernesto A Salegio
Nature Biotechnology. 2025-11-17
Press Mentions
Harnessing Bioinformatics to Fast-Track the Discovery of Spinal Cord Injury DrugOctober 28th, 2025
Stem Cell Grafts and Rehabilitation Combined Boost Spinal Cord Injury ResultsOctober 28th, 2022
The Best Countries Around the World for Medical ProgressJune 29th, 2021
Grant Support
- RR&D Gordon Mansfield Spinal Cord Injury ConsortiumVA SAN DIEGO HEALTHCARE SYSTEM2015–2030
- RR&D Gordon Mansfield Spinal Cord Injury ConsortiumVA SAN DIEGO HEALTHCARE SYSTEM2015–2030
- “Neural Stem Cells for Spinal Cord Injury: Studies leading to an IND”VA SAN DIEGO HEALTHCARE SYSTEM2024–2028
- Embryonic Stem Cell Therapy after Cervical Contusion SCI in NHPsUNIVERSITY OF CALIFORNIA, SAN DIEGO2023–2028
- A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's DiseaseUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










